161 related articles for article (PubMed ID: 21913872)
21. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Singla N; Gupta D; Birbian N; Singh J
Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
[TBL] [Abstract][Full Text] [Related]
22. Antituberculosis drug-induced hepatitis: risk factors, prevention and management.
Hussain Z; Kar P; Husain SA
Indian J Exp Biol; 2003 Nov; 41(11):1226-32. PubMed ID: 15332488
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis.
Kim SH; Kim SH; Bahn JW; Kim YK; Chang YS; Shin ES; Kim YS; Park JS; Kim BH; Jang IJ; Song J; Kim SH; Park HS; Min KU; Jee YK
Pharmacogenomics; 2009 Nov; 10(11):1767-79. PubMed ID: 19891553
[TBL] [Abstract][Full Text] [Related]
24. N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.
Santos NP; Callegari-Jacques SM; Ribeiro Dos Santos AK; Silva CA; Vallinoto AC; Fernandes DC; de Carvalho DC; Santos SE; Hutz MH
Int J Tuberc Lung Dis; 2013 Apr; 17(4):499-504. PubMed ID: 23394127
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.
Cho HJ; Koh WJ; Ryu YJ; Ki CS; Nam MH; Kim JW; Lee SY
Tuberculosis (Edinb); 2007 Nov; 87(6):551-6. PubMed ID: 17950035
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
Aithal GP
Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
[TBL] [Abstract][Full Text] [Related]
27. Predictive genetic testing for drug-induced liver injury: considerations of clinical utility.
Alfirevic A; Pirmohamed M
Clin Pharmacol Ther; 2012 Sep; 92(3):376-80. PubMed ID: 22850601
[TBL] [Abstract][Full Text] [Related]
28. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
29. The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.
Zaverucha-do-Valle C; Monteiro SP; El-Jaick KB; Rosadas LA; Costa MJ; Quintana MS; de Castro L
Tuberculosis (Edinb); 2014 May; 94(3):299-305. PubMed ID: 24793319
[TBL] [Abstract][Full Text] [Related]
30. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
Yamada S; Tang M; Richardson K; Halaschek-Wiener J; Chan M; Cook VJ; Fitzgerald JM; Elwood RK; Brooks-Wilson A; Marra F
Pharmacogenomics; 2009 Sep; 10(9):1433-45. PubMed ID: 19761367
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD
Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988
[TBL] [Abstract][Full Text] [Related]
32. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Donaldson PT; Daly AK; Henderson J; Graham J; Pirmohamed M; Bernal W; Day CP; Aithal GP
J Hepatol; 2010 Dec; 53(6):1049-53. PubMed ID: 20800921
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
[TBL] [Abstract][Full Text] [Related]
34. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
35. Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen.
Kim SH; Lee SK; Kim SH; Park HW; Chang YS; Lee KW; Jee YK
Tuberculosis (Edinb); 2013 Mar; 93(2):270-4. PubMed ID: 23153709
[TBL] [Abstract][Full Text] [Related]
36. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
[TBL] [Abstract][Full Text] [Related]
37. [The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].
Wu YM; Luo ZY; Zhang HM; Peng JF; Liu SY; Wang M
Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):467-9. PubMed ID: 20587321
[No Abstract] [Full Text] [Related]
38. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.
Parham LR; Briley LP; Li L; Shen J; Newcombe PJ; King KS; Slater AJ; Dilthey A; Iqbal Z; McVean G; Cox CJ; Nelson MR; Spraggs CF
Pharmacogenomics J; 2016 Apr; 16(2):180-5. PubMed ID: 25987243
[TBL] [Abstract][Full Text] [Related]
40. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease.
Andrade RJ; Lucena MI; Alonso A; García-Cortes M; García-Ruiz E; Benitez R; Fernández MC; Pelaez G; Romero M; Corpas R; Durán JA; Jiménez M; Rodrigo L; Nogueras F; Martín-Vivaldi R; Navarro JM; Salmerón J; de la Cuesta FS; Hidalgo R
Hepatology; 2004 Jun; 39(6):1603-12. PubMed ID: 15185301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
